Skip to main content
Log in

Dose-Dependence and Repeated-Dose Studies for Receptor/Gene-Mediated Pharmacodynamics of Methylprednisolone on Glucocorticoid Receptor Down-Regulation and Tyrosine Aminotransferase Induction in Rat Liver

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

Dose-dependent and repeated-dose effects of methylprednisolone (MPL) on down-regulation of glucocorticoid receptor messenger RNA (GR mRNA) and GR density, as well as tyrosine aminotransferase (TAT) mRNA and TAT induction by receptor/gene-mediated mechanisms in rat liver were examined. A previously developed pharmacokinetic/pharmacodynamic (PK/PD) model was used to design these studies which sought to challenge the model. Three groups of male adrenalectomized Wistar rats received MPL by iv injection: low-dose (10 mg/kg at Time 0), high-dose (50 mg/kg at Time 0), and dual-dose (50 mg/kg at Time 0 and 24 hr). Plasma concentrations of MPL, and hepatic content of free GR, GR mRNA, TAT mRNA, and TAT activity were determined. The P-Pharm program was applied for population analysis of MPL PK revealing low interindividual variation in CL and Vc values (3–14%). Two indirect response models were applied to test two competing hypotheses for GR mRNA dynamics. Indirect Pharmacodynamic Response Model I (Model A) where the complex in the nucleus decreases the transcription rate of GR mRNA better described GR mRNA/GR down-regulation. Levels of TAT mRNA began to increase at 1–2 hr, reached a maximum at 5–6 hr, and declined to the baseline at 12–14 hr after MPL dosing. The induction of TAT activity followed a similar pattern with a delay of about 1–2 hr. The low-dose group had 50–60% of the TAT mRNA and TAT induction compared to the high-dose group. Since the GR density returned to about 70% of the baseline level before the second 50 mg/kg dose at 24 hr, tolerance was found for TAT mRNA/TAT induction where only 50–60% of the initial responses were produced. Our fourth-generation model describes the dose dependence and tolerance effects of TAT mRNA/TAT induction by MPL involving multiple-step signal transduction controlled by the steroid regimen, free GR density, and GR occupancy. This model may provide the foundation for studying other induced proteins or enzymes mediated by the similar receptor/nuclear events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. A. C. Guyton. The adrenocortical hormones. In Textbook of Medical Physiology, W. B. Saunders, 1986, pp. 909–922.

  2. B. P. Schimmer and K. L. Parker. Chapter 59: Adrenocorticotropic hormones; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman (eds.), Goodman & Gilman's The Pharmacological Basis of Therapeutics, McGraw-Hill, 1996, pp. 1459–1485.

  3. D. T. Boumpas, G. P. Chrousos, R. L. Wilder, T. R. Cupps, and J. E. Balow. Glucocorticoid therapy for immuno-mediated diseases: Basic and clinical correlates. Ann. Intern. Med. 119:1198–1208 (1993).

    Article  CAS  PubMed  Google Scholar 

  4. S. L. Swartz and R. G. Dluhy. Corticosteroids: Clinical pharmacology and therapeutic use. Drugs 16:238–255 (1978).

    Article  CAS  PubMed  Google Scholar 

  5. K. H. Lew and W. J. Jusko. Pharmacodynamic modeling for cortisol suppression from fluocortolone. Eur. J. Clin. Pharmacol. 45:581–583 (1993).

    Article  CAS  PubMed  Google Scholar 

  6. L. E. Fisher, E. A. Ludwig, and W. J. Jusko. Pharmacoimmunodynamics of methylprednisolone: Trafficking of helper-T lymphocytes. J. Pharmacokin. Biopharm. 20:319–331 (1992).

    Article  CAS  Google Scholar 

  7. R. I. Scheinman, P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin Jr., Roles of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283–286 (1995).

    Article  CAS  PubMed  Google Scholar 

  8. N. Auphan, J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκBα synthesis. Science 270:286–290 (1995).

    Article  CAS  PubMed  Google Scholar 

  9. S. R. Max, J. Mill, K. Mearow, M. Konagaya, Y. Konagaya, J. W. Thomas, C. Banner, and L. Vitkovi. Dexamethasone regulates glutamine synthetase expression in rat skeletal muscle. Am. J. Physiol. 255:E397–E408 (1988).

    CAS  PubMed  Google Scholar 

  10. F. D. Boudinot, R. D'Ambrosio, and W. J. Jusko. Receptor-mediated pharmacodynamics of prednisolone in the rat. J. Pharmacokin. Biopharm. 14:469–493 (1986).

    Article  CAS  Google Scholar 

  11. A. I. Nichols, F. D. Boudinot, and W. J. Jusko. Second generation model for prednisolone pharmacodynamics in the rat. J. Pharmacokin. Biopharm. 17:209–227 (1989).

    Article  CAS  Google Scholar 

  12. D. B. Haughey and W. J. Jusko. Receptor-mediated methylprednisolone pharmacodynamics in rats: Steroid-induced receptor down-regulation. J. Pharmacokin. Biopharm. 20:333–355 (1992).

    Article  CAS  Google Scholar 

  13. Z.-X. Xu, Y.-N. Sun, D. C. DuBois, R. R. Almon, and W. J. Jusko. Third-generation model for corticosteroid pharmacodynamics: Roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver. J. Pharmacokin. Biopharm. 23:163–181 (1995).

    Article  CAS  Google Scholar 

  14. Y.-N. Sun, D. C. DuBois, R. R. Almon, and W. J. Jusko. Fourth-generation model for corticosteroid pharmacodynamics: A model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver. J. Pharmacokin. Biopharm. 26:289–317 (1998).

    Article  CAS  Google Scholar 

  15. Y.-N. Sun, L. I. McKay, D. C. DuBois, R. R. Almon, and W. J. Jusko. Pharmacokinetic/pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a receptor/gene-mediated mechanism. J. Pharmacol. Exp. Ther. 288: 720–728 (1999).

    CAS  PubMed  Google Scholar 

  16. N. L. Dayneka, V. Garg, and W. J. Jusko, Comparison of four basic models of indirect pharmacodynamic responses. J. Pharmacokin. Biopharm. 21:457–478 (1993).

    Article  CAS  Google Scholar 

  17. Y. Dong, L. Poellinger, J.-A. Gustafsson, and S. Okret. Regulation of glucocorticoid receptor expression: Evidence for transcriptional and posttranslational mechanism. Mol. Endocrinol. 2:1256–1264 (1988).

    Article  CAS  PubMed  Google Scholar 

  18. W. V. Vedeckis, M. Ali, and H. R. Allen. Regulation of glucocorticoid receptor protein and mRNA levels. Cancer Res. 49(Suppl.):2295s–2320s (1989).

    CAS  PubMed  Google Scholar 

  19. M. J. Czar, J. K. Owens-Grillo, K. D. Dittmar, K. A. Hutchison, A. M. Zacharek, K. L. Leach, M. R. Deibel Jr., and W. B. Pratt. Characterization of the protein-protein interactions determining the shock protein (hsp90.hsp70.hsp56) heterocomplex. J. Biol. Chem. 269:11155–11161 (1994).

    CAS  PubMed  Google Scholar 

  20. E. Orti, L. M. Hu, and A. Munck. Kinetics of glucocorticoid receptor phosphorylation in intact cells. Evidence for hormone-induced hyperphosphorylation after activation and recycling of hyperphosphorylated receptors. J. Biol. Chem. 268:7779–7784 (1993).

    CAS  PubMed  Google Scholar 

  21. R. M. Oakley and J. A. Cidlowski. Homologous down regulation of the glucocorticoid receptor: The molecular machinery. Crit. Rev. Eukary. Gen. Expr. 3:63–88 (1993).

    CAS  Google Scholar 

  22. P. Bernstein, S. W. Peltz, and J. Ross. The poly(A)—poly(A)-binding protein complex is a major determination of mRNA stability in vitro. Mol. Cell Biol. 9:659–670 (1989).

    CAS  PubMed Central  PubMed  Google Scholar 

  23. J. S. Malter. Identification of a AUUUA-specific messenger RNA binding protein. Science 246:664–666 (1989).

    Article  CAS  PubMed  Google Scholar 

  24. I. Segard-Maurel, K. Rajkowski, N. Jibard, G. Schweizer-Groyer, E.-E. Baulieu, and F. Cadepond. Glucocorticoid receptor dimerization investigated by analysis of receptor binding to glucocorticosteroid responsive elements using a monomer-dimer equilibrium model. Biochemistry 35:1634–1642 (1996).

    Article  CAS  PubMed  Google Scholar 

  25. A. J. Cooney and S. Y. Tsai. Nuclear receptor-DNA interactions. In M.-J. Tsai and B. W. O'Malley (eds.), Mechanism of Steroid Hormone Regulation of Gene Transcription, R. G. Landes, 1994, pp. 25–59.

  26. A. Munck and N. J. Holbrook. Glucocorticoid-receptor complexes in rat thymus cells: Rapid kinetic behavior and a cyclic model. J. Biol. Chem. 259:820–831 (1984).

    CAS  PubMed  Google Scholar 

  27. W. F. Ebling, S. J. Szefler, and W. J. Jusko. Methylprednisolone disposition in rabbits: Analysis, prodrug conversion, reversible metabolism and comparison with man. Drug Metab. Dispos. 13:296–304 (1985).

    CAS  PubMed  Google Scholar 

  28. D. Z. D'Argenio and A. Schumitzky. ADAPT II User's Guide: Pharmacokinetic/pharmacodynamic Systems Analysis Software, Biomedical Simulations Resource, Los Angeles, 1997.

    Google Scholar 

  29. O. M. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 173:265–272 (1951).

    Google Scholar 

  30. D. C. DuBois, R. R. Almon, and W. J. Jusko. Molar quantification of specific messenger ribonucleic acid expression in Northern hybridization using cRNA standards. Anal. Biochem. 210:140–144 (1993).

    Article  CAS  PubMed  Google Scholar 

  31. P. A. Krieg and D. A. Melton. In vitro RNA synthesis with SP6 RNA polymerase. Meth. Enzymol. 155:397–415 (1987).

    Article  CAS  PubMed  Google Scholar 

  32. J. M. Chirgwin, A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299 (1979).

    Article  CAS  PubMed  Google Scholar 

  33. D. C. DuBois, Z.-X. Xu, L. McKay, R. R. Almon, N. Pyszczynski, and W. J. Jusko. Differential dynamics of receptor down-regulation and tyrosine aminotransferase induction following glucocorticoid treatment. J. Steroid Biochem. Molec. Biol. 54:237–243 (1995).

    Article  CAS  PubMed  Google Scholar 

  34. J. P. Northrop, M. Danielsen, and G. M. Ringold. Analysis of glucocorticoid unresponsive cell variants using a mouse glucocorticoid receptor complementary DNA clone. J. Biol. Chem. 261:11064–11070 (1986).

    CAS  PubMed  Google Scholar 

  35. T. I. Diamondstone. Assay of tyrosine aminotransferase activity by conversion of p-hydroxyphenylpyruvate to p-hydroxybenzaldehyde. Anal. Biochem. 16:395–401 (1966).

    Article  CAS  Google Scholar 

  36. P-Pharm: Professional Desktop Data Modeling Software for Pharmacokinetics. Version 1.4, SIMED Scientific Software, France.

  37. L. Z. Benet and R. L. Galeazzi. Noncompartmental determination of the steady-state volume of distribution. J. Pharm. Sci. 68:1071–1074 (1979).

    Article  CAS  PubMed  Google Scholar 

  38. C. C. Peck, S. L. Beal, L. B. Sheiner, and A. I. Nichols. Extended least squares nonlinear regression: A possible solution to the “choice of weights” problem in analysis of individual pharmacokinetic data. J. Pharmacokin. Biopharm. 12:545–558 (1984).

    Article  CAS  Google Scholar 

  39. A. J. Bailer. Testing for the equality of area under the curves when using destructive measurement techniques. J. Pharmacokin. Biopharm. 16:303–309 (1988).

    Article  CAS  Google Scholar 

  40. J. R. Nedelman, E. Gibiansky, and D. T. W. Lau, Applying Bailer's method for AUC confidence intervals to sparse sampling. Pharm. Res. 12:124–128 (1995).

    Article  CAS  PubMed  Google Scholar 

  41. Y.-N. Sun and W. J. Jusko. Transmit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics. J. Pharm. Sci. 87:732–737 (1998).

    Article  CAS  PubMed  Google Scholar 

  42. L. I. McKay, D. C. DuBois, Y.-N. Sun, R. R. Almon, and W. J. Jusko. Corticosteroid effects in skeletal muscle: Gene induction/receptor autoregulation. Muscle Nerve 20:1318–1320 (1997).

    Article  CAS  PubMed  Google Scholar 

  43. J. Gabrielsson and D. L. Weiner. Parameter estimation. In Pharmacokinetic and Pharmacodynamic Data Analysis: Concepts and Applications, 2nd ed., Swedish Pharmaceutical Press, 1997, pp. 31–57.

  44. W. Mendenhall, D. D. Wackerly, and R. L. Scheaffer. Hypothesis testing. In Mathematical Statistics with Applications, PWS-KENT Publishing, 1990, pp. 427–491.

  45. W. J. Jusko, H. C. Ko, and W. F. Ebling. Convergence of direct and indirect pharmacodynamic response models. J. Pharmacokin. Biopharm. 23:5–8 (1995).

    Article  CAS  Google Scholar 

  46. D. B. Haughey and W. J. Jusko. Bioavailability and nonlinear disposition of methylprednisolone and methylprednisone in the rat. J. Pharm. Sci. 81:117–121 (1992).

    Article  CAS  PubMed  Google Scholar 

  47. S. J. Szefler, J. Q. Rose, E. F. Ellis, S. L. Spector, A. W. Green, and W. J. Jusko. The effect of troleandomycin on methylprednisolone elimination. J. Allergy Clin. Immunol. 66:447–451 (1980).

    Article  CAS  PubMed  Google Scholar 

  48. C. Monder and V. Lakshmi. Evidence for kinetically distinct forms of corticosteroid 11 β-dehydrogenase in rat liver microsomes. J. Steroid Biochem. 32:77–83 (1989).

    Article  CAS  PubMed  Google Scholar 

  49. H. Cheng and W. J. Jusko. Pharmacokinetics of reversible systems. Biopharm. Drug Dispos. 14:721–766 (1993).

    Article  CAS  PubMed  Google Scholar 

  50. A.-N. Kong and W. J. Jusko. Disposition of methylprednisolone and its sodium succinate prodrug in vivo and in perfused liver of rats: Nonlinear and sequential first-pass elimination. J. Pharm. Sci. 80:409–415 (1991).

    Article  CAS  PubMed  Google Scholar 

  51. M. Wakelkamp, G. Alvan, J. Gabrielsson, and G. Paintaud. Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration. Clin. Pharmacol. Ther. 60:75–88 (1996).

    Article  CAS  PubMed  Google Scholar 

  52. J. A. Bauer and H.-L. Fung. Pharmacodynamic models of nitroglycerin-induced hemodynamic tolerance in experimental heat failure. Pharm. Res. 11:816–823 (1994).

    Article  CAS  PubMed  Google Scholar 

  53. J. Shi, N. L. Benowitz, C. P. Denaro, and L. B. Sheiner. Pharmacokinetic-pharmacodynamic modeling of caffeine: tolerance to pressor effects. Clin. Pharmacol. Ther. 53:6–14 (1993).

    Article  CAS  PubMed  Google Scholar 

  54. G. Movin-Osswald and M. Hammerlund-Udenaes. Prolactin release after remoxipride by an integrated pharmacokinetic-pharmacodynamic model with intra-and interindividual aspects. J. Pharmacol. Exp. Ther. 274:921–927 (1995).

    CAS  PubMed  Google Scholar 

  55. J. J. Lima, J. J. Krukemyer, and H. Boudoulas. Drug-or hormone-induced adaptation: Model of adrenergic hypersensitivity. J. Pharmacokin. Biopharm. 17:347–364 (1989).

    Article  CAS  Google Scholar 

  56. J. J. Pink and V. C. Jordan. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res. 56:2321–2330 (1996).

    CAS  PubMed  Google Scholar 

  57. J. B. Levy, T. M. Seay, D. J. Tindall, and D. A. Husmann. The effects of androgen administration on phallic androgen receptor. J. Urol. 156:775–779 (1996).

    Article  CAS  PubMed  Google Scholar 

  58. M. Gilli, J. J. Chiu, and M. J. Lenardo. NF-κB and Rel: Participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1–62 (1993).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, YN., DuBois, D.C., Almon, R.R. et al. Dose-Dependence and Repeated-Dose Studies for Receptor/Gene-Mediated Pharmacodynamics of Methylprednisolone on Glucocorticoid Receptor Down-Regulation and Tyrosine Aminotransferase Induction in Rat Liver. J Pharmacokinet Pharmacodyn 26, 619–648 (1998). https://doi.org/10.1023/A:1020746822634

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020746822634

Navigation